Patents by Inventor Emilie CROUCHET

Emilie CROUCHET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer
    Publication number: 20230349922
    Abstract: The present invention provides Histamine Receptor 2 antagonists and pharmaceutical compositions thereof for use in the treatment or prevention of liver disease, including liver fibrosis and hepato-biliary cancers. The present invention also relates to methods for identifying candidate compounds that are useful in the treatment or prevention of liver disease, including liver fibrosis and hepato-biliary cancers.
    Type: Application
    Filed: August 11, 2021
    Publication date: November 2, 2023
    Applicants: Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale
    Inventors: Thomas Baumert, Emilie Crouchet
  • ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF FIBROTIC DISEASES
    Publication number: 20230138047
    Abstract: The present invention concerns the use of anti-Claudin-1 monoclonal antibodies, and pharmaceutical compositions thereof, for the prevention and/or treatment of a fibrotic disease in a patient, in particular pulmonary fibrosis, kidney fibrosis or skin fibrosis. Methods of preventing and/or treating pulmonary fibrosis kidney fibrosis or skin fibrosis by administration of such a monoclonal antibody, or a pharmaceutical composition thereof, are also described.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 4, 2023
    Inventors: Thomas Baumert, Emilie CROUCHET, Roberto IACONE, Markus MEYER, Natascha ROHLEN, Antonio SAVIANO, Catherine SCHUSTER, Tamas SCHWEIGHOFFER